54953-U

LiChrosorb^® RP-8 (5 µm) HPLC Columns

L × I.D. 25 cm × 4.6 mm, HPLC Column

• Synonyma: TM=["LiChrospher"] C8 HPLC column
• UNSPSC Code: 41115700
• eCl@ss: 32110501
• NACRES: SB.52
• L × i.d.: 25 cm × 4.6 mm
• Particle size: 5 μm
• Matrix active group: C8 (RP8), C8 (octyl) phase
• Pore size: 100 Å
• Matrix: octyl, fully porous particle

Vlastnosti

• Název produktu: LiChrosorb^® RP-8 HPLC Column, 5 μm particle size, L × I.D. 25 cm × 4.6 mm
• material: stainless steel column
• Quality Segment: 100
• agency: suitable for USP L7
• product line: LiChrosorb^®
• feature: endcapped: no
• analyte functional class(es): antibiotics, fat soluble vitamins, lipids, nutraceuticals and antioxidants, oils, pigments
• manufacturer/tradename: LiChrosorb^®
• packaging: 1 ea of
• extent of labeling: 9.5% Carbon loading
• parameter: ≤70 °C temp. range, 400 bar pressure (5801 psi)
• technique(s): HPLC: suitable
• L × I.D.: 25 cm × 4.6 mm
• surface area: 300 m²/g
• matrix: octyl, fully porous particle
• matrix active group: C8 (RP8), C8 (octyl) phase
• particle size: 5 μm
• pore size: 100 Å
• operating pH: 2-7.5
• separation technique: reversed phase

Popis

General description

LiChrosorb^® RP-8 HPLC column is used for the separation of neutral, acidic and weakly basic compounds.

Application

• Determination of amphotericin B, liposomal amphotericin B, and amphotericin B colloidal dispersion in plasma by high-performance liquid chromatography.: Utilizing the LiChrospher^® RP-8 HPLC Column, this study develops a method for analyzing various formulations of amphotericin B in plasma, crucial for monitoring therapeutic levels and preventing toxicity in patients undergoing antifungal treatment (Egger et al., 2001).


• Determination of doxorubicin and metabolites in murine specimens by high-performance liquid chromatography.: This research demonstrates the application of the LiChrospher^® RP-8 HPLC Column in the quantification of doxorubicin and its metabolites, enhancing the understanding of its pharmacokinetics and aiding in the optimization of cancer treatment regimens (van Asperen et al., 1998).


• Determination of glibenclamide in human plasma by solid-phase extraction and high-performance liquid chromatography.: Employing the LiChrospher^® RP-8 HPLC Column, this method provides accurate and reliable quantification of glibenclamide, a critical component in managing diabetes mellitus (Valdes Santurio and Gonzalez Porto, 1996).


• Simultaneous determination of ampicillin and metampicillin in biological fluids using high-performance liquid chromatography with column switching.: Highlighting the versatility of the LiChrospher^® RP-8 HPLC Column, this study develops a technique for the simultaneous determination of ampicillin and its prodrug, metampicillin, crucial for effective antibiotic therapy monitoring (Lee et al., 1995).

Other Notes

Discover LiChropur reagents ideal for HPLC or LC-MS analysis

Legal Information

LiChrosorb is a registered trademark of Merck KGaA, Darmstadt, Germany

LiChrospher is a registered trademark of Merck KGaA, Darmstadt, Germany

Bezpečnostní informace

• Skladovací třída: 10 - Combustible liquids
• Co se děje?: WGK 3
• Bod vzplanutí (°F): Not applicable
• Bod vzplanutí (°C): Not applicable